Immune and microRNA responses toHelicobacter muridaruminfection and indole-3-carbinol during colitis

Thus, I3C may be useful for inflammatory bowel disease patients regardless of EHH infection. The miRNA changes associated with I3C treatment are likely the result of, rather than the cause of immune response changes.